BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33139079)

  • 1. [Secondary ITP in adults].
    Michel M; Lega JC; Terriou L
    Rev Med Interne; 2021 Jan; 42(1):50-57. PubMed ID: 33139079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Challenges and potential solutions in first-line treatments for immune thrombocytopenia in adults].
    Godeau B; Bonnotte B; Michel M
    Rev Med Interne; 2021 Jan; 42(1):25-31. PubMed ID: 32713675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of ITP and AIHA in CVID: A systematic literature review].
    Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
    Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary management of primary immune thrombocytopenia in adults.
    Lakshmanan S; Cuker A
    J Thromb Haemost; 2012 Oct; 10(10):1988-98. PubMed ID: 22863415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
    Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
    Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, pathophysiology, and initial management of chronic immune thrombocytopenic purpura.
    Pruemer J
    Am J Health Syst Pharm; 2009 Jan; 66(2 Suppl 2):S4-10. PubMed ID: 19139489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older Adults and Immune Thrombocytopenia: Considerations for the Clinician.
    Crickx E; Mahévas M; Michel M; Godeau B
    Clin Interv Aging; 2023; 18():115-130. PubMed ID: 36726813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological characterisation of patients with common variable immunodeficiency related immune thrombocytopenia.
    Somasundaram N; Meyer O; Scheibenbogen C; Hanitsch LG; Stittrich A; Kölsch U; Wittke K
    Clin Exp Med; 2023 Dec; 23(8):5423-5432. PubMed ID: 37670184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary and secondary immune thrombocytopenia.
    Kado R; McCune WJ
    Curr Opin Rheumatol; 2019 May; 31(3):213-222. PubMed ID: 30920453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and Therapy of Immune thrombocytopenia].
    Matzdorff A; Wörmann B
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1076-1081. PubMed ID: 30060276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
    Liebman HA
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe chronic idiopathic thrombocytopenic purpura during childhood: definition, management, and prognosis.
    Buchanan GR; Journeycake JM; Adix L
    Semin Thromb Hemost; 2003 Dec; 29(6):595-603. PubMed ID: 14719176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and classification of immune-mediated thrombocytopenia.
    Lo E; Deane S
    Autoimmun Rev; 2014; 13(4-5):577-83. PubMed ID: 24444701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)].
    Kvezereli-Kopadze MA; Kvezereli-Kopadze AN; Mtvarelidze ZG
    Georgian Med News; 2009 Sep; (174):50-5. PubMed ID: 19801732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
    Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
    Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Thrombocytopenia in Children: Consensus and Controversies.
    Singh G; Bansal D; Wright NAM
    Indian J Pediatr; 2020 Feb; 87(2):150-157. PubMed ID: 31927692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.